Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vimal H Prajapati

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Dermatologic Therapy|August 21, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paperJensen Yeung, Marc Bourcier, Melinda J Gooderham, et al.
Dermatology and Therapy|April 25, 2025
Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical TherapiesMelinda J Gooderham, H Chih-Ho Hong, Charles Lynde, et al.
Journal of Cutaneous Medicine and Surgery|December 15, 2022
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 PathwayWei Jing Loo, Irina Turchin, Vimal H Prajapati, et al.
Dermatology and Therapy|April 20, 2025
Canadian Consensus Guidelines for the Management of VitiligoVimal H Prajapati, Harvey Lui, Yvette Miller-Monthrope, et al.
Journal of the American Academy of Dermatology|June 1, 2019
Management of pediatric plaque psoriasis using biologicsPerla Lansang, James N Bergman, Loretta Fiorillo, et al.
Journal of Cutaneous Medicine and Surgery|September 30, 2021
Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort StudyAbrahim Abduelmula, Jorge R Georgakopoulos, Asfandyar Mufti, et al.
Advances in Therapy|December 3, 2025
Efficacy of Lebrikizumab on Pruritus: A Narrative ReviewGil Yosipovitch, Brian S Kim, Sonja Ständer, et al.
Journal of the American Academy of Dermatology|January 20, 2025
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective reviewSiddhartha Sood, Alexander Rimke, Brian D Rankin, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 24, 2024
Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Short-Term (Week 8-20) Data from a Real-World Multicenter Retrospective ReviewBrian D Rankin, Siddhartha Sood, Ye-Jean Park, et al.
Journal of the American Academy of Dermatology|April 19, 2023
Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspectiveJensen Yeung, Melinda J Gooderham, H Chih-Ho Hong, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Dermatologic Therapy|August 21, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paperJensen Yeung, Marc Bourcier, Melinda J Gooderham, et al.
Dermatology and Therapy|April 25, 2025
Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical TherapiesMelinda J Gooderham, H Chih-Ho Hong, Charles Lynde, et al.
Journal of Cutaneous Medicine and Surgery|December 15, 2022
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 PathwayWei Jing Loo, Irina Turchin, Vimal H Prajapati, et al.
Dermatology and Therapy|April 20, 2025
Canadian Consensus Guidelines for the Management of VitiligoVimal H Prajapati, Harvey Lui, Yvette Miller-Monthrope, et al.
Journal of the American Academy of Dermatology|June 1, 2019
Management of pediatric plaque psoriasis using biologicsPerla Lansang, James N Bergman, Loretta Fiorillo, et al.
Journal of Cutaneous Medicine and Surgery|September 30, 2021
Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort StudyAbrahim Abduelmula, Jorge R Georgakopoulos, Asfandyar Mufti, et al.
Advances in Therapy|December 3, 2025
Efficacy of Lebrikizumab on Pruritus: A Narrative ReviewGil Yosipovitch, Brian S Kim, Sonja Ständer, et al.
Journal of the American Academy of Dermatology|January 20, 2025
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective reviewSiddhartha Sood, Alexander Rimke, Brian D Rankin, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 24, 2024
Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Short-Term (Week 8-20) Data from a Real-World Multicenter Retrospective ReviewBrian D Rankin, Siddhartha Sood, Ye-Jean Park, et al.
Journal of the American Academy of Dermatology|April 19, 2023
Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspectiveJensen Yeung, Melinda J Gooderham, H Chih-Ho Hong, et al.
Pageof 11